Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
AI may detect earliest signs of pancreatic cancer
An artificial intelligence (AI) tool developed by Cedars-Sinai investigators in the USA accurately predicted who…
Structural bio paired with computational design to create anticancer agent
Researchers at the Paul Scherrer Institute PSI and the Italian Institute of Technology IIT have…
How air pollution alters lung tissue, increasing cancer susceptibility
Scientists have identified a mechanism that explains how fine air pollution particles might cause lung…
ASCO 2019: Entrectinib gets edge over crizotinib against ROS1 lung cancer
- ASCO 2019: Combination checkpoint blockade effective in pre-surgical setting for early-stage lung cancers
- ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung cancer
- ASCO 2019: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors
DNA vaccine leads to immune responses in HPV-related head and neck cancer
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumours and fight off human papillomavirus (HPV)-related head…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.